Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
Invacare Corporation (NYSE:IVC) today announced that it received notice from the New York Stock Exchange (the "NYSE") that the
According to Benzinga Pro data, during Q2, Invacare (NYSE:IVC) posted sales of $189.02 million. Earnings were up 9.32%, but Invacare still reported an overall loss of $21.94 million.
Invacare Corporation (NYSE:IVC) today announced that it has entered into a cooperation agreement with its largest shareholder, Azurite Management LLC ("Azurite"), which currently owns